Modern Action logo
IssuesBillsBriefingNewsletterAbout
Donate
Donate
Modern Action

Navigation

Menu

01HomeFront page→02IssuesActive issue pages→03BillsLegislation index→04BriefingDaily context→05NewsletterWeekly Watchlist→06AboutMission and team→07DonateSupport the work→

Account

Sign In→Get Started→
Modern Action

Find the bills behind the news, understand what Congress can do, and contact your representatives with a specific message.

Platform

  • Contact Congress
  • Write to Congress
  • Browse Bills
  • Track Bills

Resources

  • Find My Representatives
  • Contact My Representatives
  • How to Contact Representatives
  • Does Contacting Congress Work?
  • Newsletter

Support

  • About
  • Contact Us
  • Press
  • Accessibility

Legal

  • Privacy Policy
  • Terms of Service
  • Cookie Policy
  • Accessibility

Stay informed about legislation

Get weekly updates on important bills and how to take action.

© 2026 Modern Action. All rights reserved.

Made with ❤️ for democracy
All systems operational

Contact Congress about H.R. 2756: National Biotechnology Initiative Act of 2025

The White House would lead a new national biotechnology effort across many federal agencies. A new office would coordinate research, product rules, safety work, worker training, and public reports.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

National Biotechnology Initiative Act of 2025 is a House bill in committee. The latest recorded action: Referred to the Committee on Science, Space, and Technology, and in addition to the Committees on Foreign Affairs, Agriculture, Energy and Commerce, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Latest action on H.R. 2756: Referred to the Committee on Science, Space, and Technology, and in addition to the Committees on Foreign Affairs, Agriculture, Energy and Commerce, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Who this affects: This bill mainly affects federal agencies, biotech researchers, biotech companies, workers, students, and people whose health, food, environment, or data may be touched by biotechnology. Agencies would have new planning and reporting duties. Companies and researchers could get clearer rules and more coordinated support. Workers and students could see more biotech training programs.

Why this matters: Biotech touches daily life through medicine, food, farming, energy, the environment, and national security. Today, many agencies handle different pieces of that work, which can make the system hard to follow. This bill tries to make federal biotech work more organized and easier to use. It also raises practical questions about data privacy, safety rules, agency power, and industry influence.

Key provisions in H.R. 2756

  • The President would have to lead a National Biotechnology Initiative from the Executive Office of the President. The effort would cover many federal departments and agencies.
  • At least 13 federal bodies would take part. They include Agriculture, Commerce, Defense, Energy, Health and Human Services, Homeland Security, Interior, State, the Environmental Protection Agency, NASA, the National Science Foundation, the Director of National Intelligence, and the U.S. Trade Representative. More could be added.
  • The bill would create a National Biotechnology Coordination Office inside the Executive Office of the President. A Director would lead it and serve as the President's main biotechnology adviser.
  • The new office would handle many parts of federal biotech policy. Its work would include planning, national security reviews, research priorities, biological data, help bringing products to market, clearer rules, safety and security planning, workforce training, public biotech education, and international work.
  • The bill would create a committee so agencies can work together on the Initiative. Each participating agency would send an Assistant Secretary-level official, and three co-chairs would rotate over time.

How Modern Action helps you take action on H.R. 2756

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 2756

What is H.R. 2756?
The White House would lead a new national biotechnology effort across many federal agencies. A new office would coordinate research, product rules, safety work, worker training, and public reports.
How do I support or oppose H.R. 2756?
Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.
Who should I contact about H.R. 2756?
Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.
Can Modern Action explain H.R. 2756 before I act?
Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.

Keep acting on Modern Action

More ways to act on this issue

Compare the broader issue and related bills without leaving Modern Action.

Related bills

  • Take action on S. 1387: National Biotechnology Initiative Act of 2025